172 related articles for article (PubMed ID: 37203167)
1. Thrombosis Occurrence in COVID-19 Compared With Other Infectious Causes of ARDS: A Contemporary Cohort.
Coy-Canguçu A; Locachevic GA; Mariolano JCS; Soares KHO; Oliveira JD; Vaz CO; Vieira-Damiani G; Mazetto B; Annichino-Bizzacchi JM; De Paula EV; Orsi FA
Clin Appl Thromb Hemost; 2023; 29():10760296231175656. PubMed ID: 37203167
[TBL] [Abstract][Full Text] [Related]
2. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study.
Helms J; Tacquard C; Severac F; Leonard-Lorant I; Ohana M; Delabranche X; Merdji H; Clere-Jehl R; Schenck M; Fagot Gandet F; Fafi-Kremer S; Castelain V; Schneider F; Grunebaum L; Anglés-Cano E; Sattler L; Mertes PM; Meziani F;
Intensive Care Med; 2020 Jun; 46(6):1089-1098. PubMed ID: 32367170
[TBL] [Abstract][Full Text] [Related]
3. Venous Thromboembolism Events Following Venovenous Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Syndrome Coronavirus 2 Based on CT Scans.
Parzy G; Daviet F; Puech B; Sylvestre A; Guervilly C; Porto A; Hraiech S; Chaumoitre K; Papazian L; Forel JM
Crit Care Med; 2020 Oct; 48(10):e971-e975. PubMed ID: 32618700
[TBL] [Abstract][Full Text] [Related]
4. The impact of protocol-based high-intensity pharmacological thromboprophylaxis on thrombotic events in critically ill COVID-19 patients.
Atallah B; Sadik ZG; Salem N; El Nekidy WS; Almahmeed W; Park WM; Cherfan A; Hamed F; Mallat J
Anaesthesia; 2021 Mar; 76(3):327-335. PubMed ID: 33047335
[TBL] [Abstract][Full Text] [Related]
5. Systemic thrombosis in a large cohort of COVID-19 patients despite thromboprophylaxis: A retrospective study.
Muñoz-Rivas N; Abad-Motos A; Mestre-Gómez B; Sierra-Hidalgo F; Cortina-Camarero C; Lorente-Ramos RM; Torres-Rubio P; Arranz-García P; Franco-Moreno AI; Gómez-Mariscal E; Mauleón-Fernández C; Alonso-García S; Rogado J; Saez-Vaquero T; Such-Diaz A; Ryan P; Moya-Mateo E; Martín-Navarro JA; Hernández-Rivas JA; Torres-Macho J; Churruca J;
Thromb Res; 2021 Mar; 199():132-142. PubMed ID: 33503547
[TBL] [Abstract][Full Text] [Related]
6. Prophylactic anticoagulants for people hospitalised with COVID-19.
Flumignan RL; Tinôco JDS; Pascoal PI; Areias LL; Cossi MS; Fernandes MI; Costa IK; Souza L; Matar CF; Tendal B; Trevisani VF; Atallah ÁN; Nakano LC
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013739. PubMed ID: 33502773
[TBL] [Abstract][Full Text] [Related]
7. Factors Associated With Risk of Postdischarge Thrombosis in Patients With COVID-19.
Li P; Zhao W; Kaatz S; Latack K; Schultz L; Poisson L
JAMA Netw Open; 2021 Nov; 4(11):e2135397. PubMed ID: 34807256
[TBL] [Abstract][Full Text] [Related]
8. Incidence and effects of deep vein thrombosis on the outcome of patients with coronavirus disease 2019 infection.
Marini CP; Lewis E; Petrone P; Zenilman A; Lu Z; Rivera A; McNelis J
J Vasc Surg Venous Lymphat Disord; 2022 Jul; 10(4):803-810. PubMed ID: 34775121
[TBL] [Abstract][Full Text] [Related]
9. Deep vein thrombosis in hospitalized patients with coronavirus disease 2019.
Chang H; Rockman CB; Jacobowitz GR; Speranza G; Johnson WS; Horowitz JM; Garg K; Maldonado TS; Sadek M; Barfield ME
J Vasc Surg Venous Lymphat Disord; 2021 May; 9(3):597-604. PubMed ID: 33039545
[TBL] [Abstract][Full Text] [Related]
10. [Deep venous thrombosis incidence in patients with COVID-19 acute respiratory distress syndrome, under intermediate dose of chemical thromboprophylaxis].
Hunter M; Lurbet MF; Parodi J; Mandó F; Bonelli I; Rodríguez PO; López Saubidet I
Medicina (B Aires); 2022; 82(2):181-184. PubMed ID: 35417380
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 and Thrombosis: Clinical Aspects.
Urano T; Yasumoto A; Yokoyama K; Horiuchi H; Morishita E; Suzuki Y
Curr Drug Targets; 2022; 23(17):1567-1572. PubMed ID: 36200150
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary embolism or thrombosis in ARDS COVID-19 patients: A French monocenter retrospective study.
Contou D; Pajot O; Cally R; Logre E; Fraissé M; Mentec H; Plantefève G
PLoS One; 2020; 15(8):e0238413. PubMed ID: 32853267
[TBL] [Abstract][Full Text] [Related]
13. Venous thromboembolism in critically ill patients affected by ARDS related to COVID-19 in Northern-West Italy.
Longhitano Y; Racca F; Zanza C; Piccioni A; Audo A; Muncinelli M; Santi R; Kozel D; Geraci C; Taverna M; Bonato V; Cassini F; Franceschi F
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(17):9154-9160. PubMed ID: 32965007
[TBL] [Abstract][Full Text] [Related]
14. Deep vein thrombosis and pulmonary embolism among hospitalized coronavirus disease 2019-positive patients predicted for higher mortality and prolonged intensive care unit and hospital stays in a multisite healthcare system.
Erben Y; Franco-Mesa C; Gloviczki P; Stone W; Quinones-Hinojoas A; Meltzer AJ; Lin M; Greenway MRF; Hamid O; Devcic Z; Toskich B; Ritchie C; Lamb CJ; De Martino RR; Siegel J; Farres H; Hakaim AG; Sanghavi DK; Li Y; Rivera C; Moreno-Franco P; O'Keefe NL; Gopal N; Marquez CP; Huang JF; Kalra M; Shields R; Prudencio M; Gendron T; McBane R; Park M; Hoyne JB; Petrucelli L; O'Horo JC; Meschia JF
J Vasc Surg Venous Lymphat Disord; 2021 Nov; 9(6):1361-1370.e1. PubMed ID: 33836287
[TBL] [Abstract][Full Text] [Related]
15. Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection.
Obi AT; Barnes GD; Napolitano LM; Henke PK; Wakefield TW
J Vasc Surg Venous Lymphat Disord; 2021 Jan; 9(1):23-35. PubMed ID: 32916371
[TBL] [Abstract][Full Text] [Related]
16. Deep Vein Thrombosis in Hospitalized Patients With COVID-19 in Wuhan, China: Prevalence, Risk Factors, and Outcome.
Zhang L; Feng X; Zhang D; Jiang C; Mei H; Wang J; Zhang C; Li H; Xia X; Kong S; Liao J; Jia H; Pang X; Song Y; Tian Y; Wang B; Wu C; Yuan H; Zhang Y; Li Y; Sun W; Zhang Y; Zhu S; Wang S; Xie Y; Ge S; Zhang L; Hu Y; Xie M
Circulation; 2020 Jul; 142(2):114-128. PubMed ID: 32421381
[TBL] [Abstract][Full Text] [Related]
17. Management, control, and decision making in unexpected recurrent venous thromboembolism in COVID-19: a case report.
Zolfaghari Emameh R; Heshmatnia J
J Med Case Rep; 2023 Mar; 17(1):101. PubMed ID: 36934279
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of a patient specific, targeted-intensity pharmacologic thromboprophylaxis protocol in hospitalized patients with COVID-19.
Farrar JE; Trujillo TC; Mueller SW; Beltran L; Nguyen C; Hassell K; Kiser TH
J Thromb Thrombolysis; 2022 Feb; 53(2):446-453. PubMed ID: 34410561
[TBL] [Abstract][Full Text] [Related]
19. COVID-19-associated coagulopathy in children: A multicenter observational cohort study.
Zabeida A; Winikoff R; Pelland-Marcotte MC; Charlebois J; Sabapathy C
Pediatr Blood Cancer; 2023 Jan; 70(1):e30079. PubMed ID: 36326142
[TBL] [Abstract][Full Text] [Related]
20. The potential link between Covid-19 and multiple myeloma: A new saga.
Al-Kuraishy HM; Al-Gareeb AI; Mohammed AA; Alexiou A; Papadakis M; Batiha GE
Immun Inflamm Dis; 2022 Dec; 10(12):e701. PubMed ID: 36444620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
